Literature DB >> 26844944

Impaired Left Ventricular Reserve in Childhood Cancer Survivors Treated With Anthracycline Therapy.

Sachie Kaneko1, Edythe B Tham1, Mark J Haykowsky2, Maria Spavor1, Nee S Khoo1, Andrew S Mackie1, Jeffrey F Smallhorn1, Richard B Thompson3, Michael D Nelson2.   

Abstract

BACKGROUND: Childhood cancer survivors show evidence of diffuse myocardial fibrosis that is related to exercise capacity. The mechanism of reduced exercise tolerance in anthracycline cardiotoxicity remains unclear. We explored the determinants of exercise intolerance by evaluating left ventricular (LV) distensibility and functional reserve.
METHODS: Patients (n = 22) and healthy controls (n = 10) underwent two-dimensional echocardiography while supine, upright, and during cycle exercise. LV distensibility was measured as the change in end-diastolic cavity area (EDCA) from supine to the upright position. LV functional reserve was assessed during peak exercise, and measured as the exercise-induced change in systolic circumferential strain rate (SR) and early-diastolic SR (EDSR). The peak rate of oxygen consumption was measured by indirect calorimetry.
RESULTS: Median age of patients was 16 years (range 8-19) and controls 14 years (range 8-19). Median time since anthracycline therapy was 6 years (range 2-16). Peak oxygen consumption was significantly lower in patients compared to controls (35 ml/kg/min [28-60] vs. 45 ml/kg/min [44-53], P = 0.005). Transitioning from the supine position to the upright position caused a similar reduction in LV EDCA, suggesting similar LV distensibility between patients (-22% [-46 to -4]) and controls (-20% [-46 to -3], P = 0.3). However, during exercise, both systolic SR and EDSR reserve were significantly impaired in patients (∆SR: 93% [14-308], ∆EDSR: -4.5% [-88 to 121]) compared to controls (∆SR: 128% [54-230], P = 0.046; ∆EDSR: 74% [22-234], P = 0.02).
CONCLUSIONS: Our findings suggest that impaired LV contractility and functional reserve play a role in the reduced exercise capacity in anthracycline cardiotoxicity rather than LV distensibility.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  cardiomyopathy; diastolic function; echocardiography; exercise testing; strain imaging

Mesh:

Substances:

Year:  2016        PMID: 26844944     DOI: 10.1002/pbc.25933

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  6 in total

1.  Short and long-term impairments of cardiopulmonary fitness level in previous childhood cancer cases: a systematic review.

Authors:  Vesile Yildiz Kabak; Patrick Calders; Tulin Duger; Jibril Mohammed; Eric van Breda
Journal:  Support Care Cancer       Date:  2018-09-25       Impact factor: 3.603

2.  Acute and late toxicities of pirarubicin in the treatment of childhood acute lymphoblastic leukemia: results from a clinical trial by the Japan Association of Childhood Leukemia Study.

Authors:  Hiroki Hori; Tooru Kudoh; Shinichiro Nishimura; Megumi Oda; Makoto Yoshida; Junichi Hara; Akio Tawa; Ikuya Usami; Akihiko Tanizawa; Keiko Yumura-Yagi; Koji Kato; Ryoji Kobayashi; Yoshihiro Komada; Keitaro Matsuo; Keizo Horibe
Journal:  Int J Clin Oncol       Date:  2016-11-17       Impact factor: 3.402

3.  Physical activity and fitness in childhood cancer survivors: a scoping review.

Authors:  Matthew D Wogksch; Chelsea G Goodenough; Emily R Finch; Robyn E Partin; Kirsten K Ness
Journal:  Aging Cancer       Date:  2021-12-21

4.  Cardiopulmonary Exercise Testing Characterizes Silent Cardiovascular Abnormalities in Asymptomatic Pediatric Cancer Survivors.

Authors:  Takeshi Tsuda; Daphney Kernizan; Austin Glass; Gina D'Aloisio; Jobayer Hossain; Joanne Quillen
Journal:  Pediatr Cardiol       Date:  2022-09-08       Impact factor: 1.838

Review 5.  Echocardiographic Assessment of Cardiotoxic Effects of Cancer Therapy.

Authors:  Wendy J Bottinor; Christopher K Migliore; Carrie A Lenneman; Marcus F Stoddard
Journal:  Curr Cardiol Rep       Date:  2016-10       Impact factor: 2.931

6.  Vo2peak in Adult Survivors of Hodgkin Lymphoma: Rate of Decline, Sex Differences, and Cardiovascular Events.

Authors:  Raheel Rizwan; Kimberlee Gauvreau; Cheryl Vinograd; Jessica M Yamada; Christina Mangano; Andrea K Ng; Mark E Alexander; Ming Hui Chen
Journal:  JACC CardioOncol       Date:  2021-06-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.